Clinical significance of disease‐specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma
暂无分享，去创建一个
Y. Hasegawa | A. Matsumura | Y. Suehara | S. Chiba | N. Obara | M. Sakata-Yanagimoto | S. Takano | H. Nishikii | N. Kurita | E. Ishikawa | Y. Yokoyama | Takayasu Kato | K. Hattori | Hidekazu Nishikii | Naoki Kurita